CACI International Inc (NYSE: CACI) — Proof Arrived; So Did the Premium

Report date: 2026-09-01 · Price: $623.01 (2026-08-31 close) · Shares outstanding: 22.099M · Market capitalization: ~$13.77B · Enterprise value: ~$18.96B · Fiscal year-end: June 30

⚡ Claude’s Take

The author’s subjective opinion; general information, not investment advice. The analytical body below carries no recommendation.

Verdict: HOLD / avoid chasing at ~$623; accumulate on material weakness in roughly the $530–570 zone. Framing: a quality-improving, results-driven compounder whose operating proof arrived at almost the same moment as a full repricing.

CACI did nearly everything the July report required. FY2026 organic growth reached 7.2% and accelerated to 11.6% in the fourth quarter; EBITDA margin expanded 110 basis points to 12.3%; free cash flow excluding the receivables facility rose to $735M; and management’s pro-forma leverage fell from 4.2x to 3.7x in one quarter. Technology revenue grew 16.9%, funded backlog rose 29%, and FY2027 guidance implies another ~7% of organic growth plus margin expansion. The operating thesis is stronger, and the prior low-single-digit-growth bear case has been materially weakened.

The price has also risen ~24% since the July 2 report and ~53% from the June low, with the FY2026 release producing CACI’s largest one-day gain in at least five years. At $623, the shares trade at ~18.6x FY2027 adjusted EPS, ~13.8x a reasonable FY2027 EBITDA estimate, and a 6.5% yield on management’s headline FCF guide—but closer to a 5.4% yield after removing identifiable tax timing benefits and treating stock compensation as an owner cost. That is defensible for current execution, not obviously mispriced. A broad $530–570 entry zone corresponds to roughly 16–17x guided adjusted EPS and offers more room for fixed-price execution risk, a back-half-weighted organic guide, and the still-unproved return on ARKA. Conviction: medium. More bullish if ARKA produces disclosed incremental returns while leverage reaches the low 3s without another major deal; more bearish if fixed-price estimate revisions turn unfavorable or organic growth misses the back-half ramp. Tag: the bear lost the operating argument; the valuation argument remains.

🔄 Changes Since the 2026-07-02 Report

The thesis framing changed, but the balance of evidence did not become one-sided. In July, the central restraint was a mix of unproved post-ARKA execution, elevated leverage, and merely fair valuation. Today, execution is much less speculative: FY2026 beat the prior operating tests, leverage moved faster than expected, and FY2027 guidance is stronger than the old base case. The remaining analytical restraint is now principally the price paid for that evidence.

• Confirmed: CACI is gaining from the national-security and differentiated-technology mix. FY2026 revenue grew 10.9%, organic revenue 7.2%, Technology revenue 16.9%, operating income 20.4%, and EBITDA margin 110 basis points.
• Bear case weakened: the prior test of high-single-digit organic growth, margin accretion, and visible deleveraging is substantially passing. Q4 organic growth was 11.6%; pro-forma leverage fell to 3.7%; management expects low-3x leverage by June 2027.
• Still unproved: ARKA has produced strategic cross-selling and a revenue bridge, but no standalone EBITDA, cash conversion, or incremental return disclosure. Consolidated ROIC fell after acquisition capital entered the balance sheet.
• New risk emphasis: federal policy now favors fixed-price and performance-based contracting. CACI’s fixed-price mix already rose to 30.4%, creating margin opportunity and greater cost-estimation risk.
• Valuation changed: the price rose from $502.83 to $623.01. The stale July own-history percentile is not reused; current embedded expectations are rebuilt from filing-reconciled enterprise value, FY2027 guidance, peer returns, and normalized cash flow.
• Corrections: the July memo conflated Department of Defense exposure with broader national security, federal revenue with prime-contractor revenue, and overstated top-ten contract concentration. FY2026 was 53.6% Department of War, 24.6% Intelligence Community, 95.6% federal, and 90.1% prime. The filing reports top-ten contracts at 22.5% of revenue, though the sharp fall from 46.4% in FY2025 needs reconciliation before being treated as structural diversification.

📈 Stock Price Action — Five-Year Event Map

CACI’s adjusted close rose 142.9% from $256.47 on 2021-09-01 to $623.01 on 2026-08-31. The five-year closing range was $243.64–$680.08; the latest price was 8.4% below the high and within a trailing-52-week intraday range of $434.73–$683.50. Price moves below are facts; the cited drivers are interpretations cross-checked against filings and contemporary news.

The first drawdown followed a quarter in which EPS fell 8.4%, EBITDA 9.5%, and FCF 32.6% year over year. The subsequent climb was progressively supported by operating evidence: Q3 FY2024 delivered 10% organic growth and higher guidance, while Q1 FY2025 delivered 9.9% organic growth and another raise (historical SEC earnings exhibits). The late-2024 selloff was a sector-level reassessment after federal-efficiency appointments, not a commensurate collapse in CACI’s results (Reuters).

The 2025 recovery gained company-specific support when Q1 FY2026 produced 11.2% revenue growth, 24% EBITDA growth, $5.0B of awards, and a 2.2x book-to-bill. The early-2026 decline overlapped a federal funding fight and the debt-financed March 9 ARKA close (ARKA closing 8-K). The final move was unambiguous: CACI’s FY2026 results and FY2027 guidance drove a 21.4% one-day gain on August 6, the largest daily advance in this five-year record.

1. Executive Summary

CACI International is a $9.57B revenue government-technology contractor with roughly 27,000 employees. It combines technical labor—engineering, mission support, cyber, enterprise IT, data and software delivery—with increasingly product-like capabilities in electronic warfare, signals intelligence, photonics, secure communications, counter-unmanned aircraft systems, and space sensing. Management labels the two capability sets Expertise and Technology, but the financial statements report only Domestic and International geographic segments. That distinction matters: the strategically important mix shift is visible in revenue, not in capability-level profit or invested capital.

The customer base is concentrated by design. In FY2026, 95.6% of revenue came from the U.S. federal government: 53.6% from the Department of War, 24.6% from the Intelligence Community, and 17.4% from federal civilian agencies. Commercial and other customers were 4.4%. CACI earned 90.1% of revenue as a prime contractor. The result is unusually high customer credit quality and demand visibility, offset by government monopsony: the customer sets procurement rules, audits costs, can shift funding, and can terminate contracts for convenience.

The operating record is strong. From FY2022 through FY2026, revenue compounded 11.5%, operating income 16.7%, and diluted EPS 11.8%; operating margin rose from 8.0% to 9.61%. FY2026 was better still: 7.2% organic growth, 16.9% Technology growth, 12.3% EBITDA margin, and a 137% company-defined FCF-to-net-income ratio. The cash result requires normalization, but it accelerated deleveraging after ARKA. FY2027 guidance calls for $10.65–10.85B of revenue, $32.96–33.86 of adjusted EPS, and at least $900M of FCF. After roughly $500M of acquired revenue, midpoint organic growth is about 7.1%.

The quality debate is not settled by growth. CACI’s competitive advantages are real at the program level: security clearances, facility accreditations, past performance, contract vehicles, embedded mission knowledge, and the cost of replacing an incumbent team. Those barriers protect the class of scaled cleared primes from outsiders more than they protect CACI from Leidos, Booz Allen, SAIC, Parsons, or GDIT. CACI calls itself a small participant in a highly competitive addressable market. A scope-imperfect public-peer share proxy suggests that CACI gained share, but consolidated ROIC remains only 8–11% over the cycle and fell after ARKA. That is evidence of good execution, not a wide economic franchise.

Capital allocation is therefore decisive. ARKA and Datalynx cost $2.643B; 98.7% of consideration became goodwill or acquired intangibles. Azure Summit was also 92.8% goodwill and intangibles. Total goodwill and intangibles now equal $8.56B, 72.4% of assets, while tangible equity is negative. The acquisitions may be strategically sound, but reported revenue synergy and falling leverage do not prove that the purchase prices earn an adequate return. Management compensation reinforces this concern because incentives reward absolute revenue, EBITDA, and FCF without ROIC, organic-growth, per-share, or relative-return gates.

The immediate operating setup is constructive. Backlog is $32.0B, funded backlog $5.4B, awards $10.2B, and book-to-bill 1.1x. Management says 83% of FY2027 revenue is existing work, 9% recompetes, and only 8% new business. The risk is the shape: Q1 organic growth is expected to be low single digit with acceleration later, and federal policy is pushing the industry toward fixed-price structures that transfer cost risk to the contractor. The FY2026 10-K shows that favorable contract-estimate changes added $25.3M to pretax income after unfavorable changes subtracted $15.8M in FY2025—a $41.1M swing worth monitoring.

At $623.01, the market recognizes much of the improvement. Current enterprise value is about 16.2x FY2026 EBITDA and roughly 13.8x a reasonable FY2027 estimate. The headline forward FCF yield is 6.5%, but identifiable tax/refund timing and stock compensation reduce the recurring-owner-cash lens to about 5.4%. The valuation is not extravagant relative to 7% organic growth and improving margins, yet it offers limited protection if ARKA returns disappoint, fixed-price execution reverses, or the back-half growth ramp slips.

2. Business Overview

What CACI sells

CACI describes its mission as providing Expertise and Technology to national-security and government-modernization customers. The labels can sound generic, so the economic distinction is more useful than the marketing language.

Expertise is principally human capital applied to difficult government missions: intelligence analysis, engineering, network operations, enterprise IT, cyber operations, logistics, litigation support, and other technical or functional work. This activity can be highly specialized and sticky, especially when employees hold scarce clearances and know classified workflows. Economically, however, much of it remains labor monetized through hours, negotiated rates, and allowable costs.

Technology includes agile software, DevSecOps, data platforms, AI-enabled workflows, open architectures, network modernization, electromagnetic-spectrum systems, signals intelligence, secure communications, photonics, counter-UAS systems, and space sensors. Some offerings combine hardware, software, and engineering rather than resemble commercial licensed software. That is why CACI’s margin profile—9.6% operating and 12.3% EBITDA—is superior to commodity staff augmentation but far below a scalable software franchise.

FY2026 Technology revenue was $5.583B, 58.4% of the total, and grew 16.9%; Expertise was $3.985B and grew 3.5%. This is the cleanest evidence that portfolio mix improved. Yet CACI does not disclose Technology EBITDA, organic growth excluding acquired businesses, invested capital, or cash conversion. Investors can see the strategic direction but cannot independently calculate whether the differentiated capability set earns a higher return.

Customers and concentration

The national-security conclusion is stronger than any single agency label. Department of War plus Intelligence Community revenue was 78.2%, insulating CACI from some of the civil-consulting retrenchment that damaged peers. Prime status matters because CACI owns the direct customer relationship on nine-tenths of revenue. It also assumes responsibility for contract performance and may carry subcontractor execution risk.

These customer and prime-contractor figures come from Item 7 and Note 20 of the FY2026 Form 10-K; they replace the mislabeled figures in the July report.

The ten largest revenue-producing contracts represented $2.2B, or 22.5% of FY2026 revenue, down from $4.0B and 46.4% in FY2025. The apparent diversification is favorable only if like-for-like. CACI does not explain whether the fall arose from contract aggregation, recompete treatment, or a genuine redistribution of revenue, so the prudent conclusion is that concentration is lower as reported, not necessarily structurally halved.

Contract economics

Cost-plus work reimburses allowable costs and pays a fee. It stabilizes economics but caps upside and makes labor hours a revenue input. Time-and-materials contracts pay negotiated rates for labor and materials, leaving utilization and wage-rate risks. Firm-fixed-price work sets the consideration in advance: reusable intellectual property, engineering discipline, and automation can increase profit, while underestimating labor, material, or schedule requirements can destroy it.

The mix shift is important because Executive Order 14402 makes fixed-price and performance-based contracting the federal default; non-fixed Department of War contracts above $100M require agency-head approval, and agencies must review their ten largest non-fixed contracts. The FAR states that a firm-fixed-price structure places maximum cost risk and full responsibility on the contractor. CACI requires at least two executive approvals for significant fixed-price bids, a sensible control but not immunity from estimation error.

Backlog and revenue visibility

FY2026 awards were $10.2B, book-to-bill 1.1x, total backlog $32.0B, and funded backlog $5.4B. Total backlog rose only 1.9%; funded backlog rose 28.6%. The distinction is crucial. Funded backlog represents authorized amounts and is the more concrete near-term indicator. Unfunded backlog includes expected future task orders, options, and contract ceilings that may never convert. The nearly six-year average duration of awards supports customer continuity, but it does not mean six years of irrevocable revenue.

Management’s FY2027 bridge—83% existing work, 9% recompetes, 8% new business—makes near-term revenue unusually visible. The principal uncertainties are funding timing, program pace, staffing, and the amount of ceiling converted to funded task orders. Contractual revenue is therefore more durable than ordinary project consulting but less recurring than subscription software.

Reporting, workforce, and geographic mix

Domestic Operations produced $9.260B of FY2026 revenue, about 96.8% of the total, at a 9.29% operating margin. International Operations generated $307.5M at a 19.49% margin. The international unit is attractive but too small to drive the consolidated economics. Domestic margin improvement from 8.15% in FY2024 to 9.29% in FY2026 demonstrates that the recent step-up is not merely mix from the high-margin international tail.

The roughly 27,000-person workforce is both asset and constraint. Security clearances are costly and time-consuming; employees carry mission knowledge that cannot be recreated instantly or offshored. Conversely, labor availability can cap organic growth, wage inflation can pressure fixed-price programs, and key personnel often move between contractors when a recompete changes hands. The company—not its factories—is the organization that recruits, clears, retains, and coordinates that human capital.

Revenue recognition adds another layer of judgment. Many long-term arrangements use cost-to-cost measures of progress, so current revenue and margin depend on estimates of total future cost. This is standard government-contract accounting, but it means a reported quarter combines work performed with updated expectations about the rest of the program. Contract assets capture revenue recognized before billing; receivables and the MARPA facility affect when that accounting profit becomes cash. The more the portfolio moves toward fixed price, the more important these estimates become.

CACI is understandable at the economic level even though capability disclosure is coarse: it converts cleared labor, customer access, past performance, and acquired mission technology into contracted revenue. It cannot be undercut simply by foreign low-cost labor because much of the work is classified, performed in secure facilities, or restricted to U.S. persons. It can still be underbid by another cleared prime, displaced by customer insourcing, or out-innovated by a nontraditional entrant. That combination explains why revenue is stable while excess returns are harder to sustain.

3. Industry Dynamics

An attractive demand pool with a powerful buyer

Federal technology services combine long-duration, appropriations-backed demand with structurally limited supplier pricing power. National-security missions do not disappear when the economy slows, and high switching friction makes existing programs durable. Yet the U.S. government is not an ordinary customer. It writes procurement rules, audits cost systems, controls appropriations, can insource work, mandates small-business participation, delays awards through continuing resolutions, and terminates contracts for convenience.

This produces a moderately attractive industry rather than a textbook high-return one. The established primes benefit from customer captivity and qualification barriers, but the government captures much of the economic rent. Price remains a stated award factor, and CACI itself says no competitor is dominant and that it owns a relatively small share of its addressable market.

Competitive map

The closest scaled competitors are Leidos, Booz Allen Hamilton, SAIC, Parsons, and General Dynamics Information Technology, alongside technology-specific defense primes and many small-business specialists. Nontraditional cloud, cyber, satellite, and software providers are entering. For differentiated technology, competitors also include venture-backed defense-technology firms whose commercial-development cadence may be faster than traditional contracting processes.

Peer scope is imperfect: fiscal years differ, GDIT is embedded with Mission Systems, and tax rates distort reported returns. Still, the evidence is directionally useful. CACI’s 10.9% FY2026 growth and 9.6% operating margin compare well with slower-growing service peers. Leidos and normalized Booz Allen returns demonstrate that CACI’s 8.2% ROIC is not simply an unavoidable industry ceiling.

Procurement regime change

The federal shift toward fixed-price, performance-based, commercial-item, and faster acquisition structures has two effects. First, it rewards contractors able to deliver reusable technology, defined outcomes, and internally funded product development. CACI’s 30.4% fixed-price mix is already ahead of Booz Allen’s roughly 21% mix in Q1 FY2027, and CACI expanded margins as the mix rose. Second, it transfers risk from the government to the supplier. Frontier physics, changing mission requirements, and undefined scope are difficult to price. A company can report higher backlog and margins until a single estimate-at-completion revision exposes prior underbidding.

CACI recognizes revenue on many long-term contracts using cost-to-cost estimates and records a full expected loss when estimated cost exceeds revenue. FY2026 favorable and unfavorable estimate changes added a net $25.3M to pretax income after subtracting $15.8M in FY2025. The $41.1M year-over-year swing was about 5.8% of FY2026 pretax income. The relevant leading indicators are therefore estimate revisions, loss provisions, cash conversion, and unbilled receivables—not merely the fixed-price percentage.

Budget cycle and the civil-versus-national-security split

The 2024–25 DOGE shock demonstrated that “government contractor” is not one homogeneous factor. Civil advisory and management-consulting programs were more vulnerable to termination and efficiency review; defense, intelligence, cyber, space, border security, and electromagnetic-spectrum missions were more durable. CACI’s 78.2% Department of War plus Intelligence Community mix placed it on the favorable side of that rotation.

That insulation is relative. Continuing resolutions and shutdown threats still delay starts and awards. The customer can redirect funds even within favored missions. CACI’s FY2027 growth is expected to be low single digit in Q1 and stronger later, so funding and award timing can make the year look weaker before the backlog converts. The company is not macro-cyclical in the industrial sense, but it is politically and administratively cyclical.

Capital-cycle lens

Defense technology, cyber, counter-UAS, and space sensing attract capital because demand is growing and procurement pathways are becoming faster. CACI and peers are buying capability assets; venture capital is funding new entrants; and commercial technology companies can enter through Other Transaction Authorities and commercial-solution openings. Scarce clearances and qualification histories constrain supply, but the capital response has begun.

Marathon’s capital-cycle lesson is that strong end demand does not guarantee strong shareholder returns when capital floods into the supply base or acquisition prices rise. CACI’s total assets grew 36.7% in FY2026, while ROIC fell. Physical capex rose, but the dominant investment was acquired goodwill and intangibles. This is a yellow signal: the industry can remain healthy while returns on the newest capital disappoint.

Industry verdict: structurally stable demand, real entry barriers, and favorable current national-security priorities make the industry moderately attractive for incumbent primes. Government monopsony, price competition, procurement volatility, and an expanding supply of defense-tech capital prevent broad pricing power. The company-specific winners will be those that combine mission differentiation with disciplined bidding and acquisition returns.

4. Competitive Position

Greenwald moat classification

CACI’s moat is narrow and program-specific. It has elements of all three defensible Greenwald categories, but none is decisive at the whole-company level.

Customer captivity. On an active classified program, replacing CACI can require transferring cleared employees, rebuilding institutional knowledge, accrediting systems, and accepting execution risk. Past performance affects future awards; prime status preserves customer access; and long-lived missions create repeated interactions. These are real switching costs. They attach to programs and teams, however, and the government periodically recompetes the work. Employees may transfer to the winner, reducing captivity.

Scale economies. A scaled prime can spread compliance, security infrastructure, bid-and-proposal spending, contract vehicles, and invest-ahead technology over a large revenue base. It can staff nationwide and absorb procurement delays that would strain a smaller firm. But Leidos, Booz Allen, SAIC, Parsons, and GDIT enjoy similar scale. CACI’s scale excludes many small entrants without giving it cost dominance over the peer group.

Government protection and qualification. Clearances, facility accreditation, DCAA-compatible cost systems, export controls, security rules, and past performance make entry slow. Yet these protections qualify the established prime cohort; they are not an exclusive CACI license. Brand matters to procurement officers only insofar as it represents proven performance, compliance, and mission trust—not consumer preference.

Share and returns tests

A rough share proxy across CACI, Leidos, Booz Allen, SAIC, and Parsons moved from approximately 16.0%, 34.4%, 20.9%, 17.8%, and 11.0% in 2020 to 18.5%, 33.3%, 21.7%, 14.1%, and 12.3% on their latest fiscal years. CACI gained about 2.6 points. Because scopes and year-ends differ and GDIT is excluded, this is not audited market share. It nevertheless supports two conclusions: the incumbent cohort is stable, and CACI has probably gained relative scale.

The stronger test is return on capital. Filing-reconciled third-party ROIC was 8.2% in FY2026 versus 10.0% in FY2025 and roughly 8–11% since FY2020. A separately reproducible calculation yields 8.8% versus 10.9%, with the same direction. Neither meets a 15–25% sustained-return threshold for a strong franchise. CACI’s operating margin is improving, but acquisition capital arrived faster than NOPAT.

This prevents a common analytical shortcut: backlog is not a moat, clearances are not a company-specific moat, and technology labels are not proof of intellectual-property pricing power. The 10-K says CACI’s solutions generally are not substantially dependent on patent, copyright, trademark, or other IP protection. Differentiation rests on integration, know-how, customer relationships, and execution.

Where CACI is actually differentiated

CACI appears strongest where acquired products combine with embedded government missions: electromagnetic-spectrum operations, signals intelligence, photonics, secure communications, counter-UAS, and space sensing. These markets demand more than generic labor and can use hardware/software developed before a specific award. Technology revenue growing 16.9% while Expertise grew 3.5%, alongside a 110-basis-point EBITDA-margin expansion, is consistent with—not proof of—better economics.

The first cited CACI-plus-ARKA opportunity, NITE-STAR, combines legacy ground software and mission integration with ARKA spacecraft and payload capability. That is strategically coherent cross-selling. Its contract value, expected revenue, margin, and incremental return are undisclosed, so it cannot yet validate the $2.643B purchase price. Likewise, the three-year $500M SkyValor counter-UAS IDIQ ceiling is evidence of relevance, not guaranteed revenue; task-order conversion determines economics.

AI: capability, productivity tool, or threat?

Management says AI shortens the software lifecycle, improves quality, and can increase program profitability. That mechanism is plausible on fixed-price work because productivity gains accrue to the contractor. It is ambiguous on the 69.6% of revenue that remains cost-plus or time-and-materials: fewer labor hours can reduce billable revenue unless customers redeploy savings to more scope.

Generic models are available to peers and create no network effect by themselves. A defensible advantage would require proprietary mission data access, accredited workflows, reusable software, and measurable cycle-time improvement. CACI discloses no AI revenue, bookings, margin, R&D, adoption, or productivity series. The appropriate classification today is execution tool and demand enabler, not independent moat.

Counterarguments

The bullish counterargument is that reported ROIC is temporarily depressed because ARKA contributed only part-period earnings against a full purchase price. That is correct: a TTM metric includes only several months of acquired EBITDA, while the FY2027 guide contains a full-year contribution. Pro-forma leverage already fell. A full-cycle return judgment is premature.

The bearish counterargument is stronger than merely “M&A is bad.” CACI has repeatedly acquired the differentiated capabilities used to justify its premium, while consolidated returns remain ordinary. If product economics were exceptionally strong, the company could disclose capability margins or acquisition returns. It does not. The burden is therefore on future organic growth, cash conversion, and incremental returns to demonstrate that the purchased assets create value rather than only scale.

Competitive-position verdict: CACI is a strong operator inside a protected prime-contractor cohort, with narrow advantages in classified and technology-rich programs. It has not shown a wide company-level moat. The evidence supports share capture and improved mix; it does not yet support durable excess returns on total capital.

5. Growth History and Forward Opportunities

Five-year growth record

Revenue compounded 11.5%, operating income 16.7%, and diluted EPS 11.8% from FY2022 to FY2026. The different rates tell the story. Margin expansion created genuine operating leverage. Net income compounded only 9.9% because interest and acquisition amortization absorbed part of the operating improvement. Falling diluted shares helped per-share growth.

The series is reconciled across CACI’s FY2022 through FY2026 audited statements; CAGR calculations are derived from those filings.

The record mixes organic growth and acquisition. FY2024 and FY2025 included Azure Summit and other capability additions; FY2026 included ARKA and Datalynx from their acquisition dates. The cleanest current organic measure is management’s 7.2% for FY2026. That is strong for the industry and refutes the prior low-single-digit bear test, but it is lower than consolidated growth and should not be confused with a fully organic 11.5% five-year CAGR.

FY2027 bridge

The growth profile is attractive but back-half weighted. Management expects low-single-digit organic growth in Q1 and acceleration later as awards and funding convert. This creates a measurable checkpoint: weak early growth is not automatically a miss, but failure to show sequential acceleration would undermine the guide.

Opportunity set

Electromagnetic spectrum and electronic warfare. Modern conflict increases demand for sensing, jamming, communications resilience, signals processing, and open architectures. Azure Summit added photonics and electronic-warfare capabilities. These programs can carry higher technology content and fixed-price opportunity, while complex integration increases delivery risk.

Space sensing and mission integration. ARKA brings spacecraft, payloads, electro-optical/infrared and hyperspectral sensing; legacy CACI brings ground software, communications, and mission integration. NITE-STAR is the first cited combined award. The addressable cross-sell is credible because the assets meet on the same mission chain. The economic proof requires disclosed orders, margins, cash conversion, and returns—not a contract name.

Counter-UAS. SkyValor was selected for the first task order under a three-year $500M IDIQ. Counter-drone demand is strategically urgent and procurement is accelerating. An IDIQ ceiling is not backlog, and the competitive landscape includes established primes and fast-moving nontraditional entrants. The upside is rapid task-order conversion; the counter-test is low revenue realization despite headline ceiling values.

Software, cyber, and AI-enabled delivery. CACI can use automation to shorten development and can sell mission software under faster procurement pathways. Fixed-price programs let it retain some productivity savings. On cost-based work, the growth opportunity depends on customers redeploying saved hours to added mission scope. Measurable adoption and margin data are absent.

Share gain within a fragmented market. The public-peer revenue proxy suggests CACI gained relative share. Its addressable market is much larger than current revenue, and no competitor is dominant. This permits continued growth without requiring the end market to expand at the same rate. It also means competitors can bid aggressively; share gain must be judged alongside margin and ROIC.

Constraints

Growth can be limited by clearance capacity, hiring, appropriations timing, protests, task-order delays, and management’s ability to integrate acquisitions. A large backlog can mask slower new awards for a time, while a 1.1x book-to-bill is healthy but not extraordinary. The FY2027 guide also assumes roughly $500M of acquisition carryover; acquired revenue should not be rewarded twice as both strategic progress and organic execution.

Growth verdict: CACI has a credible mid-to-high-single-digit organic path plus ARKA carryover, supported by funded backlog and favored missions. FY2026 meaningfully upgraded confidence. The next proof points are the back-half FY2027 organic ramp, technology growth excluding acquisition, and evidence that new space/counter-UAS wins convert into cash at attractive returns.

6. Financial Quality

Profitability and operating leverage

CACI expanded operating margin from 8.00% in FY2022 to 9.61% in FY2026. FY2026 operating income grew 20.4% on 10.9% revenue growth; EBITDA rose to $1.174B at a 12.3% margin from roughly 11.2% in FY2025. Domestic margin reached 9.29%, demonstrating broad operating improvement rather than reliance on the small International unit.

Not all improvement is structural. FY2026 contract-estimate changes contributed $25.3M pretax, versus a $15.8M drag in FY2025. Removing only that year-over-year swing would moderate, not erase, the margin expansion. ARKA also contributed part-period acquired economics. The right conclusion is that execution improved materially, with some favorable estimation and mix effects that should not be extrapolated mechanically.

Cash flow and conversion

The table reconciles two different lenses. GAAP CFO includes the cash effect of the Master Accounts Receivable Purchase Agreement; company-defined FCF removes MARPA and subtracts capital expenditures. The five-year median FCF-to-net-income conversion is approximately 91%, a healthy through-cycle signal. Annual conversion is volatile because government billing, collections, taxes, and working capital move across fiscal boundaries.

Cash-flow figures are drawn from the audited statements and the company’s FY2026 cash-flow reconciliation; the conversion ratios are arithmetic rather than management KPIs.

FY2026’s 137% conversion is not a clean recurring rate. Management attributes the jump partly to immediate domestic R&D deductions under tax legislation, collections, and working-capital timing. FY2027’s at-least-$900M guide includes about $40M of delayed tax refund and $115M of Section 174 cash-tax benefit. Subtracting those identifiable items gives roughly $745M before other timing, close to FY2026’s reported company-defined FCF rather than a new $900M recurring base.

Stock compensation is also an economic cost. It rose from $31.7M, or 0.51% of revenue, in FY2022 to $79.5M, or 0.83%, in FY2026. FY2026 FCF less stock compensation was about $656M. This does not make company FCF misleading; it means an owner’s per-share cash lens should account for dilution or the cash required to offset it.

Capital intensity and intangible economics

Physical capex was modest for most of the period, roughly equal to depreciation in FY2024 and FY2025. It increased to $106.7M, or 1.37x depreciation, in FY2026. The business is not factory-intensive, but calling it capital-light without qualification misses the acquisition strategy. The principal capital expenditure occurs through purchased goodwill, customer relationships, and developed technology.

Goodwill plus acquired intangibles were $8.557B at FY2026, 72.4% of total assets and 191.7% of equity. Tangible equity was negative $4.095B, or about negative $185 per share. These assets are not inherently worthless: they represent customer relationships, technology, clearances, teams, and future cash flows that accounting cannot record organically. But they remove tangible book as a downside anchor and make acquisition returns central to financial quality.

Balance sheet and debt service

FY2026 principal debt was $4.931B and cash $191.8M. Simple net debt divided by reported EBITDA was 4.04x. Management’s 3.7x pro-forma covenant measure includes acquisition earnings and permitted adjustments; both measures are valid for different questions. The former describes current reported burden, while the latter describes lender compliance and a more complete ARKA earnings run rate.

Debt consisted of a $660M revolver, $1.234B term loan, $739M Term Loan B, $798M Term Loan B-2, and $1.5B of 6.375% notes. Revolver availability was $1.34B; $1.5B of floating exposure was swapped fixed. Reported EBITDA covered interest about 5.45x. A 100-basis-point move on unswapped floating debt would change annual interest by roughly $15M—material but manageable relative to cash flow.

The credit agreement generally caps consolidated total net leverage at 4.5x and requires 3.0x minimum interest coverage. A qualifying acquisition permits 5.0x for the acquisition quarter and three following quarters; ARKA’s window runs through the December 2026 quarter before returning to 4.5x. Permitted EBITDA adjustments include pro-forma acquisition effects, transaction costs, SBC, and limited expected synergies. CACI was compliant at June 2026, but exact covenant headroom cannot be inferred from reported ratios alone.

ROIC, ROE, and accounting quality

The two ROIC methods differ through tax, lease, cash, and invested-capital treatments; their direction agrees. FY2026 margins expanded while ROIC fell because the full acquisition-funded capital increase entered the denominator before a full year of acquired earnings. That timing argues against declaring the acquisition a failure, but it also prevents operational growth from being treated as value creation by default.

GAAP and adjusted earnings answer different questions. Acquisition amortization is noncash and may understate current cash earning power; excluding it entirely obscures what shareholders paid for acquired relationships and technology. Adjusted EPS is useful for run-rate comparability, while GAAP income and ROIC are necessary for judging acquisition economics. An honest owner-earnings lens sits between them and deducts stock compensation.

Financial-quality verdict: cash conversion is healthy through the cycle, margins are improving, and liquidity is adequate. Quality is limited by working-capital/tax volatility, acquisition-adjusted reporting, elevated leverage, and sub-10% consolidated ROIC. CACI is operationally high quality but not yet high-return on all the capital shareholders have supplied.

7. Capital Allocation

Acquisitions dominate the record

ARKA and Datalynx cost $2.643B net of acquired cash. Preliminary purchase accounting assigned $1.463B to goodwill, $660M to customer relationships with a 13.5-year life, and $485M to developed technology with a 20.9-year life. Only about $35M was net tangible assets. From acquisition dates through June, the businesses contributed $166.8M of revenue and $17.4M of GAAP net income, including $26.0M of amortization; transaction costs were $22.5M plus $3.3M of bridge fees.

Those values are from Note 4 of the FY2026 Form 10-K, whose audit also identified ARKA intangible valuation as a critical audit matter.

A rough annualization implies around $534M of revenue and 4.9x purchase-price-to-revenue, but that calculation combines Datalynx, assumes an unrepresentative stub period, and says nothing about EBITDA or cash flow. Management’s roughly $500M FY2027 acquired-revenue bridge is consistent with the annualization. The acquisition may be strategically excellent; the filing does not yet prove an adequate return.

Azure Summit cost $1.310B in FY2025. Goodwill and intangibles represented 92.8% of the price. CACI disclosed combined post-close revenue for Azure, Applied Insight, and Identity Solutions but not Azure’s standalone EBITDA, cash flow, or return. The same recurring disclosure gap applies: strategic capability is visible, purchase-price economics are not.

Debt before optionality

ARKA was funded with debt, including an incremental $800M Term Loan B-2 and additional notes. The immediate allocation priority is deleveraging. Pro-forma leverage fell 0.5 turn in Q4 to 3.7%, and management expects low 3s by June 2027, one quarter earlier than previously planned. If achieved, this would restore flexibility and materially reduce the bear case.

The discipline test is what happens next. Rapid deleveraging followed by another large acquisition would perpetuate the cycle without proving returns. The strongest signal would be explicit incremental-ROIC disclosure and a period of balance-sheet repair before renewed large-scale M&A. Revenue synergy and leverage reduction are necessary, not sufficient, measures of value creation.

Repurchases, dividends, and dilution

CACI pays no dividend. Diluted shares declined 6.3% from FY2022 to FY2026, assisted by repurchases at attractive historical prices: 0.5M shares at an average $318.99 in FY2024 and 0.4M at $344.35 in FY2025. No open-market program repurchases occurred in FY2026; $187.3M of authorization remained. Period-end shares rose 0.5% because debt displaced buybacks while equity compensation continued.

Repurchasing below later market prices was accretive, but historical price success is not itself proof of process. The more relevant question is opportunity cost: every dollar used for repurchases competes with debt reduction and acquisitions. With simple net leverage above 4x, debt reduction currently has a certain return equal to avoided interest and reduces covenant risk.

Incentives and insider behavior

FY2025 annual incentives for the CEO, CFO, and COO were 50% revenue and 50% EBITDA. Long-term awards were half time-based restricted stock and half performance shares measured solely on three-year cumulative absolute FCF. There was no ROIC, ROE, organic-growth, per-share, or relative-TSR gate. The CEO also received a discretionary modifier partly recognizing DOGE positioning and acquisitions.

Ownership requirements—8x salary for the CEO, 7x for the CFO, and 5x for other named executives—create exposure to the share price. Executives and directors collectively owned only 1.1%, however, and the incentive architecture can reward scale acquired with debt. Adding an incremental-return or per-share FCF measure would improve alignment.

A complete five-year SEC Form 4 archive sweep found one open-market purchase, 1,111 shares for about $273,000 in January 2022, versus roughly $31.7M of discretionary sales. There have been no purchases since September 2024. Most other transactions were grants, exercises, and tax withholding. The signal is modestly negative, not dispositive: sales are small relative to enterprise value, but insider behavior does not independently validate the current price or ARKA thesis.

Receivables facility

The Master Accounts Receivable Purchase Agreement permits CACI to sell eligible federal receivables. The cap was amended to $350M through December 18, 2026; sold receivables outstanding were $333.5M at FY2026 versus $288.9M at FY2025. The year-over-year cash contribution was $44.6M. CACI’s company-defined FCF excludes MARPA, appropriately preventing growth in the facility from masquerading as recurring cash generation.

The facility is still relevant economically. It is a financing source tied to receivables and can affect GAAP CFO, working capital, and liquidity. Readers should reconcile company-defined FCF to GAAP cash flow and monitor the outstanding balance and renewal terms.

Capital-allocation verdict: management has bought strategically coherent technology and historically repurchased shares below current prices, while deleveraging is ahead of plan. The unresolved issue is return discipline: goodwill-heavy acquisitions and incentives based on absolute growth have produced only ordinary consolidated ROIC. ARKA’s incremental cash return is the central scorecard.

8. Changes and Headwinds — Last Two Years

Portfolio transformation accelerated. Azure Summit closed in October 2024 and ARKA in March 2026, adding electronic-warfare, photonics, space-sensor, spacecraft, and geospatial-AI capability. Technology became 58.4% of revenue and grew 16.9% in FY2026. This strengthens differentiation while increasing goodwill, amortization, integration requirements, and debt.

The federal spending regime bifurcated. DOGE and anti-consulting initiatives damaged civil and advisory-heavy peers more than CACI. CACI’s 78.2% Department of War plus Intelligence Community exposure proved resilient. The remaining exposure is award timing: appropriations disputes and continuing resolutions can defer new starts even in favored missions.

Contract risk moved toward the supplier. Fixed-price revenue increased 410 basis points to 30.4% as federal policy made fixed-price/performance structures the default. FY2026 estimate changes were favorable, contributing to the margin expansion. This strengthens the near-term evidence but raises the probability that future quarters carry earnings volatility from cost overruns or scope errors.

Cash flow stepped up, with timing benefits. FY2026 company-defined FCF reached $735.4M and FY2027 guidance is at least $900M. The guide includes identifiable tax/refund timing of about $155M, and FY2026 benefited from tax and working-capital effects. Underlying cash generation improved, but the headline step-up should be normalized.

Leverage improved faster than expected. Pro-forma leverage fell from 4.2x at Q3 to 3.7x at year-end. Management targets low 3s by June 2027. This is the strongest positive change since the July report and reduces balance-sheet risk, though simple reported net leverage remains about 4.0x.

Backlog quality improved more than backlog quantity. Total backlog rose 1.9%, funded backlog 28.6%, and awards generated 1.1x book-to-bill. More near-term funding supports FY2027 visibility; low total-backlog growth means the headline should not be read as an accelerating multiyear order boom.

The earnings baseline re-rated sharply. Q4 organic growth of 11.6%, 13.0% EBITDA margin, and FY2027 guidance produced a 21.4% one-day share-price gain. CACI now sits near its five-year high. Business risk declined while valuation risk rose.

AI remains promise without a scoreboard. Management describes AI as a productivity and mission multiplier. No AI revenue, bookings, adoption, margin, or productivity KPI is disclosed. The economic impact will differ across fixed-price and cost-based contracts; this is an open operating question, not an established growth driver.

Legal and audit exposures persist. Government cost audits can disallow charges or withhold payments. A long-running Abu Ghraib-related civil judgment remains a legal/reputational tail. Neither appears existential at current scale, but a clearance, debarment, or material compliance failure would be far more severe because nearly all revenue is federal.

9. Risk Analysis

The most important interaction is between risks 1–4. A funding delay can compress the schedule on fixed-price work; a program overrun can weaken cash flow; weaker cash slows deleveraging; and elevated leverage reduces flexibility while an acquisition is still integrating. Each risk is manageable alone. Their correlation creates the downside tail.

Catastrophic loss is unlikely but not impossible. CACI has thousands of programs, high-credit-quality customers, positive cash generation, substantial liquidity, and no single contract disclosed as existential. A total equity loss would probably require severe misconduct or debarment across major agencies combined with debt stress, not an ordinary recompete loss. A realistic adverse outcome is lower organic growth, a program charge or impairment, slower debt reduction, and a valuation reset.

The apparent reduction in top-ten concentration is a mitigant only after clarification. A drop from 46.4% to 22.5% in one year is too large to treat as an organic diversification trend without understanding methodology. Likewise, no historical goodwill impairment does not eliminate economic overpayment; accounting tests can lag deterioration.

10. Valuation Discussion — Embedded Expectations

This section analyzes market-implied assumptions and scenarios. It carries no recommendation.

Current arithmetic

At $623.01 and 22.099M shares, equity value is about $13.77B. Adding $4.931B principal debt and subtracting $191.8M cash yields enterprise value around $18.51B; using third-party total-debt fields inclusive of other debt-like items yields about $18.96B. The difference illustrates why multiple comparisons should use consistent definitions. This report uses the $18.96B figure for conservatism and reconciles it to the filing.

Forward earnings, revenue, shares, and cash flow use the company’s FY2027 guidance; the illustrative EBITDA estimate applies a 12.8% margin to revenue midpoint because management guided only to the “high-12%” range.

No single measure is sufficient. Trailing EV/EBITDA looks high because ARKA’s debt entered before a full year of earnings. Adjusted EPS is useful for comparability but can make acquired intangibles appear free. Headline FCF contains identifiable timing benefits. A balanced view uses forward EBITDA, both GAAP and adjusted earnings, and normalized owner cash.

Peer context

Using current prices and latest fiscal denominators, rough EV/EBITDA is about 9.1x for Leidos, 10.4x for Booz Allen, 12.2x for SAIC, and 11.7x for Parsons, versus 16.2x trailing for CACI. CACI deserves some premium for faster growth, better current national-security mix, Technology expansion, and the partial-period ARKA denominator. Its illustrative 13.8x forward ratio narrows the gap but remains above most peers.

The premium is not justified by current consolidated ROIC. Leidos earns roughly 16.2%; SAIC 11.8%; normalized Booz Allen around 15–16%; Parsons and CACI around 8%. CACI’s valuation therefore rests on future growth, margin improvement, and acquisition maturation—not demonstrated peer-leading returns.

Reverse cash-flow expectations

A $900M FCF run rate on $13.77B equity is a 6.5% yield. In a simple perpetuity, that yield corresponds to approximately 2.5–3.5% perpetual growth at a 9–10% cost of equity. This is not an extreme embedded assumption for a company guiding roughly 7% organic growth, because growth can fade considerably and still satisfy it. It is also not no-growth pricing.

Using a normalized $745M cash base raises the implied yield requirement and shows the sensitivity to temporary tax benefits. If normalized FCF grows high single digits for several years, debt reduction can transfer value from creditors to equity even without multiple expansion. If organic growth settles at 3–4% and margins stop improving, the current enterprise value requires a lower discount rate or persistent acquisition success.

Three-year scenario framework

The table is an expectations framework, not a forecast of a specific share price.

The bear does not require a collapse in defense demand. A modest organic slowdown, one meaningful estimate revision, and a peer-like multiple would be enough because the current price capitalizes quality. The base requires execution broadly consistent with management’s FY2027 plan and no large acquisition that interrupts deleveraging. The bull requires both operational growth and evidence that Technology creates higher incremental returns.

Acquisition valuation and the right denominator

ARKA’s purchase price was roughly 4.9x crudely annualized acquired revenue. Without standalone EBITDA, cash flow, or organic growth, the acquisition cannot be valued from public disclosure. Long-lived developed-technology and customer-relationship amortization suggests management expects durable economics, but accounting lives are estimates, not competitive proof.

The acquisition creates a temporary denominator problem: trailing EBITDA undercounts full-year ARKA contribution, while enterprise value includes all acquisition debt. FY2027 forward EBITDA reduces that mismatch. The numerator problem remains: if expected synergies and acquired earnings are already in EBITDA, an investor must not separately capitalize them again as a narrative premium.

What the market appears to price correctly—and what remains debatable

The market correctly recognizes that CACI grew through sector disruption, is better aligned with defense/intelligence priorities, expanded margins, increased funded backlog, and accelerated deleveraging. It also appears to assume that FY2027’s back-half ramp occurs, fixed-price mix remains favorable, and ARKA earns enough to avoid a return problem.

The debatable expectation is not revenue. CACI can likely grow into the current multiple if guidance holds. It is whether that growth compounds per-share value after paying acquisition prices and stock compensation. An 8.2% ROIC company at a premium multiple has less room for capital-allocation error than its operating narrative implies.

Valuation verdict: current expectations are demanding but not implausible. The stock is valued as a quality-and-growth leader despite returns that have not reached that classification. Continued organic growth and deleveraging can justify the premium; evidence of higher incremental ROIC is required to expand it on fundamental grounds.

11. Variant Perception

Consensus narrative

The prevailing case is that CACI is the best-positioned mid-cap government contractor: defense/intelligence-heavy, less exposed to civil consulting cuts, increasingly differentiated through Technology, and able to compound adjusted EPS at a low-double-digit rate. FY2026 supports much of this view. The largest one-day rally in five years shows that the market had not fully anticipated the magnitude of Q4 growth, margin, cash flow, and FY2027 guidance.

Strongest bull case

CACI has demonstrated rather than merely claimed that portfolio transformation works. Technology grew 16.9%, Q4 organic growth reached 11.6%, EBITDA margin hit 13.0%, and funded backlog rose 29%. The government is shifting toward outcomes and fixed price, precisely where reusable hardware/software and execution can earn more than cost-plus labor. ARKA adds a full space-sensing stack, NITE-STAR shows immediate cross-selling, and $900M of headline FY2027 FCF can rapidly reduce debt. On this reading, temporary post-acquisition ROIC dilution and trailing multiple inflation are timing artifacts; forward earnings and deleveraging reveal a durable low-double-digit compounder.

Strongest bear case

The “technology company” description is ahead of the economics. Consolidated operating margin remains under 10%, ROIC fell to 8.2%, 72.4% of assets are goodwill and intangibles, and tangible equity is deeply negative. CACI buys many of the capabilities cited as its moat and does not disclose their standalone returns. Management incentives reward absolute revenue, EBITDA, and FCF without a return-on-capital gate. Fixed-price policy transfers more estimation risk just as leverage is elevated, and a large portion of FY2027 headline cash flow is tax timing. On this reading, CACI is a well-run roll-up whose premium capitalizes the benefits before acquisition returns are proven.

Variant view

The operating debate has moved. The differentiated insight is no longer that CACI will withstand federal disruption; FY2026 largely established that. The remaining variant is quality of growth versus price of capital. Investors focused on adjusted EPS and deleveraging see an improving compounder. Investors focused on consolidated ROIC see acquired scale that has yet to clear a demanding hurdle. Both can be correct for the next year; the disagreement resolves only when ARKA has a full-period return record.

Factor and positioning read

At August 31, CACI stood 1.7% above its 21-day EMA, 9.5% above its 50-day EMA, and 15.3% above its 200-day EMA. Raw returns were +18.7% over three months, −0.3% over six months, and +29.9% over twelve months. The contradictory windows reflect the sharp decline and rebound, not a smooth one-way trade.

FactorsToday estimated only 16% model R² before the August release, with Market, Aerospace & Defense, SmallSize, and Industrials exposures but no selected Momentum, Quality, LowVol, or Growth loading. Annual specific volatility was 32.1%; the five-year record included a 42.9% maximum drawdown. The August surge also ran against weak near-term Momentum and Industrials factor regimes. This supports a stock-specific results shock rather than a broad factor chase.

Third-party short data showed 1.10M shares short as of August 14, 6.32% of float and down 14.7% month over month. Some covering may have amplified the move, but the 3.58 days-to-cover ratio and the earnings magnitude argue against explaining it solely as a squeeze. The positioning read is strong price action with high idiosyncratic risk, not evidence of reduced fundamental risk.

12. Fact vs. Interpretation

13. Open Questions

1. What are ARKA’s standalone organic revenue growth, EBITDA, cash conversion, and incremental ROIC? Combined stub-period revenue and a cross-sell award do not answer the purchase-price question.
2. Why did top-ten contract concentration fall from 46.4% to 22.5% in one year? Was this true diversification, a recompete/aggregation change, or revised methodology?
3. How much of Technology growth is organic? Capability revenue grew 16.9%, but no acquisition-excluded Technology series or profit is disclosed.
4. What is the fixed-price risk scoreboard? Investors need estimate-at-completion changes, loss provisions, unbilled receivables, and cash conversion as mix rises.
5. How durable is FY2027 cash flow after tax timing? The $900M guide includes approximately $155M of identified benefits; working capital adds further uncertainty.
6. Will management stop at low-3x leverage? A renewed large acquisition before returns are visible would weaken confidence in discipline.
7. What are measurable AI economics? Adoption, development-cycle compression, program-margin uplift, customer savings redeployment, and lost billable hours are not disclosed.
8. How does CACI define and track share in its priority capability markets? The broad public-peer revenue proxy is too coarse for moat analysis.
9. What is the recompete win rate and funded conversion by capability? Aggregate backlog cannot distinguish sticky incumbency from optional ceilings.
10. Will incentives add incremental-return or per-share gates? Absolute FCF can rise through debt-funded acquisition even when ROIC falls.

14. What Must Be True

Bull case

• Organic growth remains at least mid-single digit after the FY2027 back-half ramp, with Technology outperforming Expertise on an acquisition-adjusted basis.
• Fixed-price productivity and reusable technology raise margins without a material adverse estimate revision or cash-conversion deterioration.
• ARKA and Azure produce incremental cash returns above CACI’s cost of capital; NITE-STAR and other cross-sells become funded, profitable revenue.
• Pro-forma leverage reaches the low 3s by June 2027 and management avoids another major acquisition until return evidence is visible.
• Stock compensation and share issuance remain below the growth in owner cash flow.

Bull falsification test: if FY2027 organic growth fails to accelerate after Q1, trailing book-to-bill falls below 1.0x, EBITDA margin is flat-to-down, or a major fixed-price loss/impairment emerges, the quality-improvement thesis is broken.

Bear case

• The FY2026 growth and margin surge reflects favorable program estimates, acquisition timing, and temporary budget mix rather than durable share gain.
• ARKA’s nearly all-intangible purchase price earns no meaningful spread over the cost of capital, keeping consolidated ROIC below 10%.
• Federal fixed-price policy exposes underbidding or scope errors, reducing cash flow while leverage remains elevated.
• AI compresses cost-plus/T&M labor faster than CACI can redeploy customer savings into new scope.
• The market eventually values CACI closer to slower-growing services peers as organic growth normalizes.

Bear falsification test: if organic growth remains high single digit, adverse contract-estimate changes stay immaterial, ARKA’s incremental return is disclosed above the cost of capital, leverage reaches the low 3s without a new major deal, and insiders make meaningful open-market purchases, the roll-up bear case is broken.

15. Public Source Appendix

The analytical body contains no investment recommendation. Market data are through 2026-08-31 unless otherwise stated. Company guidance and adjusted measures are management-defined; estimates and interpretations are identified as such. This material is general information, not investment advice.